「esi」の検索結果

Use when designing UI components, reviewing visual design, building design systems, or checking accessibility. Auto-activates on frontend design tasks and UI reviews.

日本語の概要は準備中です。原文の説明を表示しています。

Orchestrator for the Product Design skill set — turn early ideas into reviewable prototypes. Routes to the right sub-skill (get-context, research, audit, ideate, image-to-code, url-to-code, prototype, qa, share) based on where you are in the design process. Use when the user gives a high-level design goal like "design a UI for X", "prototype this idea", "rebuild this screen", "review our flow", or isn't sure which design step they need. Delegates to design-* skills.

日本語の概要は準備中です。原文の説明を表示しています。

Designs the first screen visitors see — the hero section. Layout patterns (split, centered, asymmetric, full-bleed), navbar design, headline typography, CTAs, background treatments (gradients, video, particles, 3D), scroll cues, and above-the-fold conversion strategy. Activate on 'hero section', 'landing page hero', 'above the fold', 'first impression', 'homepage header', 'navbar design', 'hero layout', 'landing page design'. NOT for full multi-page site architecture (use web-design-expert), not for SEO content strategy (use seo-visibility-expert).

日本語の概要は準備中です。原文の説明を表示しています。

Aesthetic assessment and design scoring across 6 dimensions. Use for UI critique, design review, visual quality assessment, remix suggestions. Activate on "design critique", "aesthetic review", "UI assessment", "visual quality", "design score", "remix this design". NOT for implementation (use frontend-developer), accessibility-only audits (use color-contrast-auditor), or brand identity creation.

日本語の概要は準備中です。原文の説明を表示しています。

Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Orchestrates `impeccable` for every design task inside a workflow phase. Captures intent in natural language, classifies it (design / development / copy), translates design intents into a sequence of impeccable subcommand invocations, runs them in main context with state persistence at `.claude/state/design/<slug>.json`, and returns a structured report. ALWAYS invokes `impeccable` under the hood for the underlying design move; never picks aesthetic direction itself; never writes product code directly. Per CLAUDE.md Article X.2, all design tasks in workflow phases route through this skill.

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks for a phase-gated refactoring or redesign loop - session-blind workers map and trace the area, empirical probes precede the design, an approval gate guards implementation, and a conformance audit re-checks the branch after any design change. State persists in .episteme/DESIGN-<slug>.md. Requires the refactor agent roles registered by scripts/install-codex.sh. Keywords: refactor loop, redesign, design gate, enumerate before design, conformance audit.

日本語の概要は準備中です。原文の説明を表示しています。

Kit de ferramentas de sistema de design de UI para Designer de UI Sênior, incluindo geração de design tokens, documentação de componentes, cálculos de design responsivo e ferramentas de handoff para desenvolvimento. Use para criar sistemas de design, manter consistência visual e facilitar colaboração entre design e desenvolvimento.

日本語の概要は準備中です。原文の説明を表示しています。

KPI体系設計とOKR策定支援スキル。ビジネス目標に整合したKPI設計、バランススコアカード、OKRフレームワーク、 ダッシュボード設計を提供。SMART原則、リーディング/ラギング指標の選定を支援。 Use when designing KPI frameworks, implementing OKR methodology, or creating performance measurement systems. Triggers: "KPI design", "OKR", "performance metrics", "balanced scorecard", "dashboard design", "measurement framework".

Knowledge base from the FAA Human Factors Design Standard (HF-STD-001B, 2016) — the FAA's consolidated human-factors / human-systems-integration design criteria for systems it manages, operates, or maintains. Use for requirement-level design rules on: general human-factors design principles; automation and function allocation; designing equipment for maintenance; displays, controls, and visual indicators; alarms, audio, and voice communications; the computer-human interface (information presentation, coding, interaction styles, windows, dialogue); keyboards, input devices, and workstation/workplace ergonomics; system security, personnel safety, environment, anthropometry, and user documentation; plus intended-use and tailoring guidance. It is a quantified, source-attributed synthesis (heavily citing MIL-STD-1472G, MIL-HDBK-759C, DOD-HFDG-ATCCS, NUREG-0700, NASA-STD-3000, ANSI, OSHA, ISO 9241). Complements nasa-hsi as a parallel HSI tradition from the civil-aviation domain. Scope limits: it is design criteria, NOT an HSI lifecycle/process model (use nasa-hsi, nasa-npr-7123, or dau-se-guidebook for process); it does NOT reproduce the third-party standards it cites; it is FAA-acquisition-oriented (ATC, towers, TRACONs, airway facilities), not a general consumer-UX guide; and it is thin on modern touchscreen/mobile, web, and AI-driven interface patterns and on quantitative human-reliability analysis.

日本語の概要は準備中です。原文の説明を表示しています。

ISTQB/JSTQB のテスト設計（test design）活動を支援するスキル。test-analyze が識別したテスト条件から、テスト対象の特性に応じたテスト技法（同値分割・境界値分析・デシジョンテーブル・状態遷移・カバレッジ基準・エラー推測など）を選定提案し、承認された技法で具体的なテストケース（入力値・前提・期待結果）を導出して、設計書 test-design.md（技法選定根拠・カバレッジ）とケース一覧 test-case.md の 2 本を作る。「テストケースを作って」「テストケースを設計して」「どの技法で網羅すべきか提案して」「境界値/デシジョンテーブルでテストを起こして」と依頼されたときに使う。テストコード実装（test-implement）は対象外。単発のテスト作成依頼（単にユニットテストを書きたいだけ）も対象外。/test-design <テスト対象名> で明示的に呼び出されたときのみ使用する。

Use when the user asks to "test our messaging before we scale it", "design a message-market-fit panel", or "run a 5-second comprehension test on our new tagline"; produces a message-test design spec — hypothesis, panel and recruit criteria, comprehension / 5-second / message-market-fit (Wynter-style) protocols, stimulus set drawn from the canon, success thresholds, and a stop/revise decision rule — for the TALE Evaluate phase so the message is validated before any paid scale. It designs the test; it never runs the experiment or adjudicates a claim. Not for running the panel or A/B experiment — use send-experiment-designer or ad-test-designer; not for analyzing the results — use performance-analyzer; not for authoring the message itself — use message-system-architect. 消息测试/理解度测试/面板设计/五秒测试/消息市场契合

日本語の概要は準備中です。原文の説明を表示しています。

TidyFactor Design track — code-native UI design lifecycle engine (Figma alternative). Supports all 7 stages of UI design (Discovery, Foundation, Architecture, Components, Motion, Quality, Delivery) with zero per-page CSS/JS and zero build step. Pluggable CSS foundations (Native, Tailwind utility-first, daisyUI, Hybrid, shadcn, Pico, Bootstrap, Alpine) and full Arabic/RTL support (El Messiri/Tajawal, never Amiri above 24px). Trigger on commands "study", "brief", "init", "brand", "typography", "school", "tokens", "palette", "assets", "layout", "nav-footer", "components", "page", "dashboard", "motion", "states", "flow", "i18n", "perf", "audit", "clone", "retrofit", "handoff", "deploy", or requests like "build a design system", "UI design lifecycle", "prototype this website", "Figma alternative", "نموذج أولي تفاعلي", "صمّم لوحة تحكم".

日本語の概要は準備中です。原文の説明を表示しています。

**MANDATORY prerequisite** — you MUST invoke this skill BEFORE calling the `get_design_context` Figma MCP tool. You MUST trigger this skill whenever the user wants to implement, build, port, or code up a Figma design as code. Example prompts (not exhaustive) are 'implement this Figma design', 'build this screen from Figma', 'turn this Figma into code', 'design to code'. This skill provides critical instructions and steps to the agent on how to correctly implement Figma designs in code and must NOT be skipped.

日本語の概要は準備中です。原文の説明を表示しています。

Invocable iOS design pipeline. When called with a design prompt, runs an autonomous loop: designs iOS screens in Pencil MCP following Apple HIG, reviews for taste using Design Philosophy, validates with XcodeBuildMCP, and iterates until done. Use as: /ios-design-stack "Design a [screen] for [app] with [requirements]"

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when creating new UI from scratch, doing a visual design pass, or when output risks looking like generic AI-generated design. Trigger words: UI 作成, デザイン, 画面を作る, 見た目を良く, デザイン改善, ランディング, ヒーロー, おしゃれに, AIっぽい, design pass.

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.

日本語の概要は準備中です。原文の説明を表示しています。

Write the merged Pencil design reference back into a UI implementation Issue's description. Takes the Issue number as argument, resolves the merged design PR on the `cc-ui-design-<Issue number>` branch, collects the `.pen` and snapshot paths it added, and appends (or replaces) the `## UIデザイン` section at the end of the Issue body using a lost-update-safe edit.

Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Set a redesign direction for an existing website. Analyzes the user's intent, picks a palette and visual direction, and writes the target spec (PRODUCT.md, DESIGN.md, DESIGN.json) plus a reasoning trace at stardust/direction.md. Use when the user asks to redesign a site, refresh the design, set a new design direction, define a redesign target, or invokes /stardust:direct.

日本語の概要は準備中です。原文の説明を表示しています。

Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.

日本語の概要は準備中です。原文の説明を表示しています。